Publications

• Long-Term Immunity after Vaccination against Yellow Fever in Korean Travelers.
  Jpn J Infect Dis Volume: 78 Page(s): 79 - 84
  03/21/2025 Authors: Um J; Nix CD; Messer WB; Zhu Y; Park J-S; Collins MH; Chin B
• Spatiotemporal dispersion of DENV-1 genotype V in Western Colombia.
  Virus Evol Volume: 11 Page(s): veaf018
  01/01/2025 Authors: Rojas-Gallardo D; Ferrell T; Escobar-Pereira PM; Lopez D; Giraldo B; Restrepo-Chica J; Jimenez-Posada E; Martinez-Gutierrez M; Ruiz-Senz J; Key A
• Altered Spike Immunoglobulin G Fc N-Linked Glycans Are Associated With Hyperinflammatory State in Adult Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome in Children.
  Open Forum Infect Dis Volume: 11 Page(s): ofae626
  11/01/2024 Authors: Sherman JD; Karmali V; Kumar B; Simon TW; Bechnak S; Panjwani A; Ciric CR; Wang D; Huerta C; Johnson B
• Altered spike IgG Fc N-linked glycans are associated with hyperinflammatory state in adult COVID and Multisystem Inflammatory Syndrome in Children.
  medRxiv
  07/14/2024 Authors: Sherman JD; Karmali V; Kumar B; Simon TW; Bechnak S; Panjwani A; Ciric CR; Wang D; Huerta C; Johnson B
• Neurodevelopment in preschool children exposed and unexposed to Zika virus in utero in Nicaragua: a prospective cohort study.
  Lancet Glob Health Volume: 12 Page(s): e1129 - e1138
  07/01/2024 Authors: Max R; Toval-Ruiz C; Becker-Dreps S; Gajewski AM; Martinez E; Cross K; Blette B; Ortega O; Collado D; Zepeda O
• Evidence of Ongoing Transmission of Zika Virus in Mrida, Mexico.
  Am J Trop Med Hyg Volume: 110 Page(s): 724 - 730
  04/03/2024 Authors: Earnest JT; Ciau-Carillo KJ; Kirstein OD; Che-Mendoza A; Espinoza DO; Puerta-Guardo H; Yam-Trujillo K; Parra-Cardea M; Barrera-Fuentes GA; Pavia-Ruz N
• High SARS-CoV-2 secondary infection rates in households with children in Georgia, United States, Fall 2020-Winter 2021.
  Front Public Health Volume: 12 Page(s): 1378701
  01/01/2024 Authors: Nowak KD; Lane MA; Mbanya A; Carter JR; Binion BA; Espinoza DO; Collins MH; Heaney CD; Pisanic N; Kruczynski K
• The TIRS trial: Enrollment procedures and baseline characterization of a pediatric cohort to quantify the epidemiologic impact of targeted indoor residual spraying on Aedes-borne viruses in Merida, Mexico.
  PLoS One Volume: 19 Page(s): e0310480
  01/01/2024 Authors: Earnest JT; Kirstein OD; Mendoza AC; Barrera-Fuentes GA; Puerta-Guardo H; Parra-Cardea M; Yam-Trujillo K; Collins MH; Pavia-Ruz N; Ayora-Talavera G
• Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopes.
  EBioMedicine Volume: 98 Page(s): 104875
  12/01/2023 Authors: Smith TC; Espinoza DO; Zhu Y; Cardona-Ospina JA; Bowman NM; Becker-Dreps S; Rouphael N; Rodriguez-Morales AJ; Bucardo F; Edupuganti S
• Blockade Antibody Responses in Human Subjects Challenged with a New Snow Mountain Virus Inoculum.
  Res Sq
  09/11/2023 Authors: Ibaraki M; Lai L; Huerta C; Natrajan MS; Collins MH; Anderson EJ; Mulligan MJ; Rouphael N; Moe CL; Liu P
• Visual findings in children exposed to Zika in utero in Nicaragua.
  PLoS Negl Trop Dis Volume: 17 Page(s): e0011275
  05/01/2023 Authors: Martinez E; Max R; Bucardo F; Stringer EM; Becker-Dreps S; Toval-Ruz C; Chavarria M; Melndez-Balmaceda MJ; Nuez C; Collins MH
• Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study.
  J Infect Dis Volume: 227 Page(s): 939 - 950
  04/18/2023 Authors: Stieh DJ; Barouch DH; Comeaux C; Sarnecki M; Stephenson KE; Walsh SR; Sawant S; Heptinstall J; Tomaras GD; Kublin JG
• Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial.
  Lancet Infect Dis Volume: 23 Page(s): 484 - 495
  04/01/2023 Authors: Tsalik EL; Rouphael NG; Sadikot RT; Rodriguez-Barradas MC; McClain MT; Wilkins DM; Woods CW; Swamy GK; Walter EB; El Sahly HM
• Population-Level Relative Effectiveness of the COVID-19 Vaccines and the Contribution of Naturally Acquired Immunity.
  J Infect Dis Volume: 227 Page(s): 773 - 779
  03/28/2023 Authors: Shioda K; Chen Y; Collins MH; Lopman BA
• Antibody Immunity to Zika Virus among Young Children in a Flavivirus-Endemic Area in Nicaragua.
  Viruses Volume: 15
  03/21/2023 Authors: Zepeda O; Espinoza DO; Martinez E; Cross KA; Becker-Dreps S; de Silva AM; Bowman NM; Premkumar L; Stringer EM; Bucardo F
• Blockade Antibody Responses in Human Subjects Challenged with a New Snow Mountain Virus Inoculum.
  Arch Microbiol Immunol Volume: 7 Page(s): 318 - 325
  01/01/2023 Authors: Ibaraki M; Lai L; Huerta C; Natrajan MS; Collins MH; Anderson EJ; Mulligan MJ; Rouphael N; Moe CL; Liu P
• Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum.
  J Infect Dis Volume: 226 Page(s): 1771 - 1780
  11/11/2022 Authors: Rouphael N; Beck A; Kirby AE; Liu P; Natrajan MS; Lai L; Phadke V; Winston J; Raabe V; Collins MH
• Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) Study.
  Infect Control Hosp Epidemiol Volume: 43 Page(s): 1664 - 1671
  11/01/2022 Authors: Howard-Anderson JR; Adams C; Dube WC; Smith TC; Sherman AC; Edupuganti N; Mendez M; Chea N; Magill SS; Espinoza DO
• Arboviruses as an unappreciated cause of non-malarial acute febrile illness in the Dschang Health District of western Cameroon.
  PLoS Negl Trop Dis Volume: 16 Page(s): e0010790
  10/01/2022 Authors: Ali IM; Tchuenkam VPK; Colton M; Stittleburg V; Mitchell C; Gaither C; Thwai K; Espinoza DO; Zhu Y; Jamal H
• Susceptibility to endemic Aedes-borne viruses among pregnant women in Risaralda, Colombia.
  Int J Infect Dis Volume: 122 Page(s): 832 - 840
  09/01/2022 Authors: Cardona-Ospina JA; Trujillo AM; Jimnez-Posada EV; Seplveda-Arias JC; Tabares-Villa FA; Altieri-Rivera JS; Monsalve A; Restrepo-Chica J; Osorio D; Espinoza D
• Sensitive and Stable Molecular Detection of Dengue, Chikungunya, and Zika Viruses from Dried Blood Spots.
  Am J Trop Med Hyg Volume: 107 Page(s): 296 - 299
  08/17/2022 Authors: Cardona-Ospina JA; Stittleburg V; Millan-Benavidez N; Restrepo-Chica J; Key A; Rojas-Gallardo DM; Piantadosi A; Collins MH; Waggoner JJ
• Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.
  Lancet Infect Dis Volume: 22 Page(s): 1210 - 1220
  08/01/2022 Authors: Coates EE; Edupuganti S; Chen GL; Happe M; Strom L; Widge A; Florez MB; Cox JH; Gordon I; Plummer S
• Quantifying Risk for SARS-CoV-2 Infection Among Nursing Home Workers for the 2020-2021 Winter Surge of the COVID-19 Pandemic in Georgia, USA.
  J Am Med Dir Assoc Volume: 23 Page(s): 942 - 946.e1
  06/01/2022 Authors: Dube WC; Kellogg JT; Adams C; Collins MH; Lopman BA; Johnson TM; Amin AB; Weitz JS; Fridkin SK
• Vaccination and vacci-notions: Understanding the barriers and facilitators of COVID-19 vaccine uptake during the 2020-21 COVID-19 pandemic.
  Public Health Pract (Oxf) Volume: 3 Page(s): 100276
  06/01/2022 Authors: Jacoby KB; Hall-Clifford R; Whitney CG; Collins MH
• EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil.
  Trials Volume: 23 Page(s): 185
  03/02/2022 Authors: Collins MH; Potter GE; Hitchings MDT; Butler E; Wiles M; Kennedy JK; Pinto SB; Teixeira ABM; Casanovas-Massana A; Rouphael NG
• Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A cross-sectional analysis of subjects enrolled in the COVID-19 Prevention in Emory Healthcare Personnel (COPE) study.
  Infect Control Hosp Epidemiol Volume: 43 Page(s): 381 - 386
  03/01/2022 Authors: Howard-Anderson JR; Adams C; Sherman AC; Dube WC; Smith TC; Edupuganti N; Chea N; Magill SS; Espinoza DO; Zhu Y
• TRANSFER AND DECAY OF MATERNAL ZIKA EDIII ANTIBODIES IN A BIRTH COHORT FROM NICARAGUA
  Volume: 105 Page(s): 191 - 191
  11/01/2021 Authors: Zepeda O; Espinoza D; Martinez E; Becker-Dreps S; Stringer E; Collins MH; Bucardo F
• EVALUATION AND APPLICATION OF NOVEL SEROLOGIC TOOLS FOR ASSESSING ZIKA VIRUS SPECIFIC IMMUNITY FOR SURVEILLANCE AND TRANSLATIONAL RESEARCH
  Volume: 105 Page(s): 190 - 190
  11/01/2021 Authors: Smith TC; Espinoza DO; Zhu Y; Becker-Dreps S; Bowman NM; Edupuganti S; Rodriguez-Morales AJ; Cardona-Ospina JA; Bucardo F; de Silva AM
• CORRELATION BETWEEN FLAVIVIRUS ANTIBODIES IN SERUM AND ZIKA RNA SHEDDING IN BLOOD, SALIVA, URINE, VAGINAL FLUID AND SEMEN OVER TIME
  Volume: 105 Page(s): 286 - 286
  11/01/2021 Authors: Centeno ED; Zepeda O; Reyes Y; Bowman NM; Becker-Dreps S; Collins MH; Bucardo F
• Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
  Science Volume: 373 Page(s): 1372 - 1377
  09/17/2021 Authors: Pegu A; O'Connell SE; Schmidt SD; O'Dell S; Talana CA; Lai L; Albert J; Anderson E; Bennett H; Corbett KS
• Clinical and Epidemiological Features of Acute Zika Virus Infections in Len, Nicaragua.
  Am J Trop Med Hyg Volume: 105 Page(s): 924 - 930
  08/09/2021 Authors: Bowman NM; Bucardo F; Collins MH; Reyes Y; Centeno Cuadra E; Blette B; Lakshmanane P; Guerra EP; Rubinstein R; Liou G-JA
• Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies.
  Epidemiology Volume: 32 Page(s): 518 - 524
  07/01/2021 Authors: Shioda K; Lau MSY; Kraay ANM; Nelson KN; Siegler AJ; Sullivan PS; Collins MH; Weitz JS; Lopman BA
• Neuromyelitis Optica Presenting as Infectious Meningoencephalitis: Case Report and Literature Review.
  Am J Med Sci Volume: 361 Page(s): 534 - 541
  04/01/2021 Authors: Tfaily MAH; Titanji B; Schniederjan MJ; Goodman A; Lava NS; Pouch SM; Collins MH; Adelman MW
• The Importance and Challenges of Identifying SARS-CoV-2 Reinfections.
  J Clin Microbiol Volume: 59
  03/19/2021 Authors: Babiker A; Marvil CE; Waggoner JJ; Collins MH; Piantadosi A
• Neurodevelopmental Outcomes of Children Following In Utero Exposure to Zika in Nicaragua.
  Clin Infect Dis Volume: 72 Page(s): e146 - e153
  03/01/2021 Authors: Stringer EM; Martinez E; Blette B; Toval Ruiz CE; Boivin M; Zepeda O; Stringer JSA; Morales M; Ortiz-Pujols S; Familiar I
• A flexible, pan-species, multi-antigen platform for the detection and monitoring of SARS-CoV-2-specific antibody responses.
  medRxiv
  01/27/2021 Authors: Shen H; Forgacs D; Chapla D; Moremen KW; Wells L; Hamer SA; Tompkins SM; Ross TM; Rouphael N; Edupuganti S
• Zika RNA and Flavivirus-Like Antigens in the Sperm Cells of Symptomatic and Asymptomatic Subjects.
  Viruses Volume: 13
  01/21/2021 Authors: Vanegas H; Gonzlez F; Reyes Y; Centeno E; Palacios J; Zepeda O; Hagbom M; Collins MH; Coward RM; Becker-Dreps S
• Risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seropositivity among nursing home staff.
  Antimicrob Steward Healthc Epidemiol Volume: 1 Page(s): e35
  01/01/2021 Authors: Amin AB; Kellogg JT; Adams C; Dube WC; Collins MH; Lopman BA; Johnson TM; Weitz J; Fridkin SK
• Application of SARS-CoV-2 Serology to Address Public Health Priorities.
  Front Public Health Volume: 9 Page(s): 744535
  01/01/2021 Authors: Sherman AC; Smith T; Zhu Y; Taibl K; Howard-Anderson J; Landay T; Pisanic N; Kleinhenz J; Simon TW; Espinoza D
• Editorial: Emerging and Re-emerging Vector-borne and Zoonotic Diseases.
  Front Med (Lausanne) Volume: 8 Page(s): 714630
  01/01/2021 Authors: Rodriguez-Morales AJ; Cardona-Ospina JA; Collins MH
• COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva.
  J Clin Microbiol Volume: 59
  12/17/2020 Authors: Pisanic N; Randad PR; Kruczynski K; Manabe YC; Thomas DL; Pekosz A; Klein SL; Betenbaugh MJ; Clarke WA; Laeyendecker O
• Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies.
  medRxiv
  11/16/2020 Authors: Shioda K; Lau MS; Kraay AN; Nelson KN; Siegler AJ; Sullivan PS; Collins MH; Weitz JS; Lopman BA
• Dengue in Western Uganda: a prospective cohort of children presenting with undifferentiated febrile illness.
  BMC Infect Dis Volume: 20 Page(s): 835
  11/11/2020 Authors: Boyce RM; Collins M; Muhindo R; Nakakande R; Ciccone EJ; Grounds S; Espinoza D; Zhu Y; Matte M; Ntaro M
• Remdesivir for the Treatment of Covid-19 - Final Report.
  N Engl J Med Volume: 383 Page(s): 1813 - 1826
  11/05/2020 Authors: Beigel JH; Tomashek KM; Dodd LE; Mehta AK; Zingman BS; Kalil AC; Hohmann E; Chu HY; Luetkemeyer A; Kline S
• The TIRS trial: protocol for a cluster randomized controlled trial assessing the efficacy of preventive targeted indoor residual spraying to reduce Aedes-borne viral illnesses in Merida, Mexico.
  Trials Volume: 21 Page(s): 839
  10/08/2020 Authors: Manrique-Saide P; Dean NE; Halloran ME; Longini IM; Collins MH; Waller LA; Gomez-Dantes H; Lenhart A; Hladish TJ; Che-Mendoza A
• The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.
  Sci Immunol Volume: 5
  06/11/2020 Authors: Premkumar L; Segovia-Chumbez B; Jadi R; Martinez DR; Raut R; Markmann A; Cornaby C; Bartelt L; Weiss S; Park Y
• COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva.
  medRxiv
  05/26/2020 Authors: Randad PR; Pisanic N; Kruczynski K; Manabe YC; Thomas D; Pekosz A; Klein SL; Betenbaugh MJ; Clarke WA; Laeyendecker O
• The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies.
  medRxiv
  05/10/2020 Authors: Premkumar L; Segovia-Chumbez B; Jadi R; Martinez DR; Raut R; Markmann A; Cornaby C; Bartelt L; Weiss S; Park Y
• Virus-Host Interactions Between Nonsecretors and Human Norovirus.
  Cell Mol Gastroenterol Hepatol Volume: 10 Page(s): 245 - 267
  01/01/2020 Authors: Lindesmith LC; Brewer-Jensen PD; Mallory ML; Jensen K; Yount BL; Costantini V; Collins MH; Edwards CE; Sheahan TP; Vinj J
• Serologic surveillance of maternal Zika infection in a prospective cohort in Leon, Nicaragua during the peak of the Zika epidemic.
  PLoS One Volume: 15 Page(s): e0230692
  01/01/2020 Authors: Collins MH; Zepeda O; Blette B; Jadi R; Morales M; Prez R; Liou G-JA; Montoya-Cruz M; Harris E; Becker-Dreps S
• Fatal Zika virus infection in the Americas: A systematic review.
  Int J Infect Dis Volume: 88 Page(s): 49 - 59
  11/01/2019 Authors: Cardona-Ospina JA; Henao-SanMartin V; Acevedo-Mendoza WF; Nasner-Posso KM; Martnez-Pulgarn DF; Restrepo-Lpez A; Valencia-Gallego V; Collins MH; Rodriguez-Morales AJ
• Detecting Vertical Zika Transmission: Emerging Diagnostic Approaches for an Emerged Flavivirus.
  ACS Infect Dis Volume: 5 Page(s): 1055 - 1069
  07/12/2019 Authors: Collins MH; Waggoner JJ
• Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease.
  Trop Med Infect Dis Volume: 4
  04/19/2019 Authors: Collins MH
• Human antibody response to Zika targets type-specific quaternary structure epitopes.
  JCI Insight Volume: 4
  04/18/2019 Authors: Collins MH; Tu HA; Gimblet-Ochieng C; Liou G-JA; Jadi RS; Metz SW; Thomas A; McElvany BD; Davidson E; Doranz BJ
• Prolonged Shedding of Zika Virus RNA in Vaginal Secretions, Nicaragua.
  Emerg Infect Dis Volume: 25 Page(s): 808 - 810
  04/01/2019 Authors: Reyes Y; Bowman NM; Becker-Dreps S; Centeno E; Collins MH; Liou G-JA; Bucardo F
• Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika.
  Nat Commun Volume: 10 Page(s): 938
  02/26/2019 Authors: Andrade P; Gimblet-Ochieng C; Modirian F; Collins M; Crdenas M; Katzelnick LC; Montoya M; Michlmayr D; Kuan G; Balmaseda A
• Human Norovirus Epitope D Plasticity Allows Escape from Antibody Immunity without Loss of Capacity for Binding Cellular Ligands.
  J Virol Volume: 93
  01/15/2019 Authors: Lindesmith LC; Brewer-Jensen PD; Mallory ML; Yount B; Collins MH; Debbink K; Graham RL; Baric RS
• CLINICAL AND EPIDEMIOLOGICAL FEATURES OF THE ZIKA OUTBREAK IN NICARAGUA
  Volume: 101 Page(s): 65 - 65
  01/01/2019 Authors: Bowman NM; Bucardo F; Collins MH; Reyes Y; Centeno E; Guerra QP; Rubinstein RJ; Liou G-JA; de Silva A; Sylvia B-D
• ZIKA VIRUS MEMORY B CELL RESPONSES DIFFER IN DENGUE IMMUNE AND DENGUE NAIVE INDIVIDUALS WITHIN A US-BASED TRAVELER STUDY COHORT
  Volume: 101 Page(s): 461 - 461
  01/01/2019 Authors: Markmann AJ; Tu H; Graham S; Collins M; Diehl S; de Silva A
• Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus-Specific CD8+ T Cells.
  J Immunol Volume: 201 Page(s): 3487 - 3491
  12/15/2018 Authors: Grifoni A; Costa-Ramos P; Pham J; Tian Y; Rosales SL; Seumois G; Sidney J; de Silva AD; Premkumar L; Collins MH
• Highly competent, non-exhausted CD8+ T cells continue to tightly control pathogen load throughout chronic Trypanosoma cruzi infection.
  PLoS Pathog Volume: 14 Page(s): e1007410
  11/01/2018 Authors: Pack AD; Collins MH; Rosenberg CS; Tarleton RL
• Zika in 2018: Advising Travelers Amid Changing Incidence.
  Ann Intern Med Volume: 169 Page(s): 337 - 338
  09/04/2018 Authors: Graciaa DS; Collins MH; Wu HM
• Seroepidemiology of Dengue, Zika, and Yellow Fever Viruses among Children in the Democratic Republic of the Congo.
  Am J Trop Med Hyg Volume: 99 Page(s): 756 - 763
  09/01/2018 Authors: Willcox AC; Collins MH; Jadi R; Keeler C; Parr JB; Mumba D; Kashamuka M; Tshefu A; de Silva AM; Meshnick SR
• Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
  J Infect Dis Volume: 218 Page(s): 536 - 545
  07/13/2018 Authors: Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P
• Breech at the Border: An Atypical Case of Invasive Haemophilus influenzae in a Patient on a Novel Immunotherapeutic.
  Open Forum Infect Dis Volume: 5 Page(s): ofy146
  07/01/2018 Authors: Howard-Anderson J; Satola SW; Collins MH
• Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
  J Clin Microbiol Volume: 56
  03/01/2018 Authors: Premkumar L; Collins M; Graham S; Liou G-JA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E
• EPITOPE TARGETS OF THE HUMAN ANTIBODY RESPONSE TO PRIMARY ZIKA VIRUS INFECTION
  Volume: 99 Page(s): 447 - 447
  01/01/2018 Authors: Collins M; Tu H; Gimblet-Ochieng C; Liou G-J; Jadi R; Metz S; Thomas A; McElvany B; Bowman N; Becker-Dreps S
• IMPLICATIONS OF CONGENITALLY ACQUIRED AND EARLY EXPOSURE TO ZIKA VIRUS INFECTION ON CHILD NEURODEVELOPMENT
  Volume: 99 Page(s): 522 - 522
  01/01/2018 Authors: Pujols S; Martinez Rosales E; Goldman B; Collins M; Chavarria Torrez M; Rosales Quintana L; Reyes Y; Zepeda O; de Silva A; Bucardo F
• Diagnosis and outcomes of pregnant women with Zika virus infection in two municipalities of Risaralda, Colombia: Second report of the ZIKERNCOL study.
  Travel Med Infect Dis Volume: 25 Page(s): 20 - 25
  01/01/2018 Authors: Rodriguez-Morales AJ; Cardona-Ospina JA; Ramirez-Jaramillo V; Gaviria JA; Gonzlez-Moreno GM; Castrilln-Spitia JD; Lpez-Villegas A; Morales-Jimnez E; Ramrez-Zapata V; Rueda-Merchn GE
• HOW CLOSE IS CLOSE? CHARACTERIZATION OF ZIKA AND DENGUE VIRUS CROSS-REACTIVE MEMORY B CELLS AND SERUM RESPONSES
  Volume: 99 Page(s): 447 - 448
  01/01/2018 Authors: Andrade P; Gimblet-Ochieng C; Modirian F; Collins M; Cardenas M; Montoya M; Michlmayr D; Kuan G; Balmaseda A; Coloma J
• MAPPING REACTIVITY TO ZIKA VIRUS IN MEMORY B CELLS FOLLOWING DISTINCT ANTECEDENT FLAVIVIRUS EXPOSURES
  Volume: 99 Page(s): 448 - 449
  01/01/2018 Authors: Tu H; Collins M; Liou G-J; Jadi R; De Silva A; Diehl S
• Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.
  J Virol Volume: 91
  12/15/2017 Authors: Grifoni A; Pham J; Sidney J; O'Rourke PH; Paul S; Peters B; Martini SR; de Silva AD; Ricciardi MJ; Magnani DM
• SERODIAGNOSIS OF ZIKA IN TRAVELERS RETURNING FROM FLAVIVIRUS-ENDEMIC REGIONS
  Volume: 95 Page(s): 42 - 42
  11/01/2017 Authors: Collins M; McGowan E; Jadi R; De Silva A
• Progress and Works in Progress: Update on Flavivirus Vaccine Development.
  Clin Ther Volume: 39 Page(s): 1519 - 1536
  08/01/2017 Authors: Collins MH; Metz SW
• Host response: Cross-fit T cells battle Zika virus.
  Nat Microbiol Volume: 2 Page(s): 17082
  05/25/2017 Authors: Collins M; de Silva A
• Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection.
  Emerg Infect Dis Volume: 23 Page(s): 773 - 781
  05/01/2017 Authors: Collins MH; McGowan E; Jadi R; Young E; Lopez CA; Baric RS; Lazear HM; de Silva AM
• DECIPHERING DURABLE NEUTRALIZING ANTIBODY RESPONSES TO ZIKA VIRUS
  Volume: 97 Page(s): 258 - 259
  01/01/2017 Authors: Collins M; Tu H; Liou A; Jadi R; Diehl S; de Silva A
• PRIOR DENGUE VIRUS EXPOSE SHAPES T CELL IMMUNITY TO ZIKA VIRUS IN HUMANS
  Volume: 97 Page(s): 414 - 414
  01/01/2017 Authors: Grifoni A; Pham J; O'Rourke PH; Peters B; de Silva AD; Ricciardi MJ; Silveira CG; Maestri A; de Oliveira-Pinto LM; Damasco PV
• FLAVIVIRUS SEROPREVALENCE IN THE DEMOCRATIC REPUBLIC OF THE CONGO
  Volume: 97 Page(s): 432 - 432
  01/01/2017 Authors: Willcox AC; Collins M; Boyce R; Tshefu A; de Silva A; Meshnick SR
• CLINICAL AND EPIDEMIOLOGICAL FACTORS ASSOCIATED WITH ZIKA VIRUS INFECTION IN LEON, NICARAGUA, 2016-2017
  Volume: 97 Page(s): 47 - 48
  01/01/2017 Authors: Bowman NM; Bucardo F; Reyes Y; Collins M; Centeno E; de Silva A; Becker-Dreps S
• LEVERAGING STUDIES IN RETURNED US TRAVELERS TO COMBAT EMERGING INFECTIOUS DISEASES
  Volume: 97 Page(s): 435 - 435
  01/01/2017 Authors: Liou G-JA; Collins M; de Silva A
• LONG TERM ASYMPTOMATIC DETECTION OF VIRAL RNA IN URINE AND SALIVA FOLLOWING ACUTE ZIKA INFECTION IN NICARAGUA 2016-2017
  Volume: 97 Page(s): 440 - 440
  01/01/2017 Authors: Reyes Y; Bowman N; Centeno E; Collins M; Becker-Dreps S; de Silva A; Bucardo F
• Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas.
  Front Immunol Volume: 8 Page(s): 1309
  01/01/2017 Authors: Grifoni A; Angelo MA; Lopez B; O'Rourke PH; Sidney J; Cerpas C; Balmaseda A; Silveira CGT; Maestri A; Costa PR
• Mesenteric Thrombosis Complicating Influenza B Infection.
  Am J Med Volume: 129 Page(s): e17 - e18
  06/01/2016 Authors: Collins MH; McGinn MK; Weber DJ
• Transcriptional regulation and T cell exhaustion.
  Curr Opin HIV AIDS Volume: 9 Page(s): 459 - 463
  09/01/2014 Authors: Collins MH; Henderson AJ
• The role of tissue plasminogen activator use and systemic hypercoagulability in central line-associated bloodstream infections.
  Am J Infect Control Volume: 42 Page(s): 417 - 420
  04/01/2014 Authors: Thakarar K; Collins M; Kwong L; Sulis C; Korn C; Bhadelia N
• Oral exposure to Trypanosoma cruzi elicits a systemic CD8 T cell response and protection against heterotopic challenge.
  Infect Immun Volume: 79 Page(s): 3397 - 3406
  08/01/2011 Authors: Collins MH; Craft JM; Bustamante JM; Tarleton RL
• CD8+T CELL RESPONSES IN NONLYMPHOID TISSUE AND PARASITE CONTROL DURING TRYPANOSOMA CRUZI INFECTION
  Volume: 79 Page(s): 351 - 352
  12/01/2008 Authors: Collins MH; Tarleton RL
• Presence of an IL-7R alpha(H1) memory CD8+ T cell population during persistent Trypanosoma cruzi infection
  Volume: 77 Page(s): 307 - 308
  11/01/2007 Authors: Bixby LM; Bustamante JM; Collins MH; Tarleton RL
• CD8+T cells recognize but do not eliminate T-cruzi from nonlymphoid tissue
  Volume: 75 Page(s): 198 - 198
  11/01/2006 Authors: Collins MH; Tarleton RL
• CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes.
  PLoS Pathog Volume: 2 Page(s): e77
  08/01/2006 Authors: Martin DL; Weatherly DB; Laucella SA; Cabinian MA; Crim MT; Sullivan S; Heiges M; Craven SH; Rosenberg CS; Collins MH
• Age-related alterations in NOS and oxidative stress in mesenteric arteries from male and female rats.
  J Appl Physiol (1985) Volume: 97 Page(s): 1268 - 1274
  10/01/2004 Authors: Sullivan JC; Loomis ED; Collins M; Imig JD; Inscho EW; Pollock JS